COVID-19 Outbreak-Global Gaba (CAS 56-12-2) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- 114 Pages
- Region: Global
γ-Aminobutyric acid (English: γ-Aminobutyric acid, abbreviated as GABA, chemical name: 4-aminobutyric acid, also known as aminobutyric acid, pipecolic acid. Widely distributed in plants and animals. Plants such as legumes, genus, GABA is contained in seeds, rhizomes and tissue fluids. In animals, GABA is almost exclusively found in nerve tissue, and the content in brain tissue is about 0.1-0.6 mg/g tissue. Immunological studies show that the highest concentration The region is the substantia nigra in the midbrain. GABA is an important inhibitory neurotransmitter that is deeply studied in the present, and it is involved in various metabolic activities and has high physiological activity. In the human body, GABA also directly regulates muscle tone.
The Gaba (CAS 56-12-2) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Gaba (CAS 56-12-2) industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Gaba (CAS 56-12-2) market can be split based on product types, major applications, and important countries as follows:
Key players in the global Gaba (CAS 56-12-2) market covered in Chapter 12:
Ningxiang Jiayuan Biological Technology Co., Ltd.
Anhui Laifu Hi-Tech Co., Ltd.
Hangzhou Viablife Biotech Co., Ltd.
Nanjing Shunxiang Pharmaceutical Technology Co., Ltd.
Shandong Pingju Biological Technology Co., Ltd.
Zhejiang Yiwan Biotechnology Co., Ltd.
In Chapter 4 and 14.1, on the basis of types, the Gaba (CAS 56-12-2) market from 2015 to 2025 is primarily split into:
In Chapter 5 and 14.2, on the basis of applications, the Gaba (CAS 56-12-2) market from 2015 to 2025 covers:
Pharmaceuticals & Health
Food & Beverage
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
Europe (Covered in Chapter 8 and 14)
Asia-Pacific (Covered in Chapter 9 and 14)
Middle East and Africa (Covered in Chapter 10 and 14)
South America (Covered in Chapter 11 and 14)
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025